NCT02366858

Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: AdventHealth · Academic / Other
• Sex: All
• Age: 18 Years – 89 Years
• Healthy volunteers: Not accepted

Summary

The investigators hypothesis is that a 22 gauge needle can yield core tissue, obviating the need to use the 19 gauge needle for core tissue procurement.

Detailed description

Inclusion Criteria 1. Age under 19 years 2. Pregnant women will be excluded. This will be confirmed by self-report Exclusion Criteria 1. Age under 19 years 2. Pregnant women will be excluded. This will be confirmed by self-report

Conditions

• Pancreatic Cancer

Interventions

Type	Name	Description
PROCEDURE	19 gauge	Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 19 gauge needle
PROCEDURE	22 gauge	Evaluate the ability to perform molecular marker or immunohistochemistry studies on tissue procured with a 22 gauge needle

Timeline

• Start date: 2013-10-01
• Primary completion: 2015-06-01
• Completion: 2015-06-01
• First posted: 2015-02-19
• Last updated: 2017-02-14

Locations

1 site across 1 country: United States